SCHEMBL599396

SCHEMBL599396

COc1c2ccccc2cc2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.67
KDM4E B2RXH2 3/20 0.67
MAPK1 P28482 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
POLB P06746 1/20 0.58
ERN1 O75460 1/20 0.55
TUBB4A P04350 1/20 0.51
TUBB P07437 1/20 0.51
TUBA3C P0DPH7 1/20 0.51
TUBA1B P68363 1/20 0.51
TUBA4A P68366 1/20 0.51
TUBB4B P68371 1/20 0.51
TUBB3 Q13509 1/20 0.51
TUBB2A Q13885 1/20 0.51
TUBB8 Q3ZCM7 1/20 0.51
TUBA3E Q6PEY2 1/20 0.51
TUBA1A Q71U36 1/20 0.51
TUBA1C Q9BQE3 1/20 0.51
TUBB6 Q9BUF5 1/20 0.51
TUBB2B Q9BVA1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30949367 1.00 ALDH1A1 (0.67) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
Boric Acid SCHEMBL28424228 0.91 ERN1 (0.57) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL29118946 0.91 ALDH1A1 (0.56) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL29703007 0.86 CYP1A2 (0.59) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL29104917 0.86 CYP1A2 (0.59) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL23089913 0.86 ALDH1A1 (0.50) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL16920395 0.86 CYP1A2 (0.50) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL27861347 0.86 ALDH1A1 (0.50) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL22126649 0.86 KDM4E (0.50) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB
SCHEMBL28702859 0.86 CYP1A2 (0.59) ALDH1A1KDM4EMAPK1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111574436-B Method for preparing anthracycline dimer by photocatalysis 山东理工大学 2023-04-28 CN claimed
US-11193058-B2 Method for controlling charge-transfer co-crystals growth NATIONAL GUARD HEALTH AFFAIRS (SA) 2021-12-07 US claimed
US-20210024822-A1 METHOD FOR CONTROLLING CHARGE-TRANSFER CO-CRYSTALS GROWTH NATIONAL GUARD HEALTH AFFAIRS (SA) 2021-01-28 US claimed
CN-101679332-A Method for producing propylene oxide SUMITOMO CHEMICAL CO 2010-03-24 CN claimed
EP-0938413-B1 RADIATION-SENSITIVE COMPOSITIONS AND PRINTING PLATES KODAK POLYCHROME GRAPHICS CO (US) 2004-03-03 EP claimed
EP-0938413-A1 RADIATION-SENSITIVE COMPOSITIONS AND PRINTING PLATES Kodak Polychrome Graphics (US) 1999-09-01 EP claimed
US-5919601-A COMPRISING THERMAL-ACTIVATED ACID GENERATOR, CROSSLINKING RESIN, BINDER RESIN CONTAINING PENDANT GROUPS CAPABLE OF UNDERGOING ACID-CATALYZED CONDENSATION WITH CROSSLINKING RESIN, INFRARED ABSORBER KODAK POLYCHROME GRAPHICS, LLC (US) 1999-07-06 US claimed
WO-1998021038-A1 RADIATION-SENSITIVE COMPOSITIONS AND PRINTING PLATES KODAK POLYCHROME GRAPHICS (US) 1998-05-22 WO claimed
EP-0537879-B1 Aryl triflate compound, radiologically acid producing agent, radiologically acid producing agent system, and radiosensitive composition HITACHI CHEMICAL CO LTD (JP) 1998-04-29 EP claimed
EP-0537879-A1 Aryl triflate compound, radiologically acid producing agent, radiologically acid producing agent system, and radiosensitive composition HITACHI CHEMICAL CO., LTD. (JP) 1993-04-21 EP claimed
US-5198402-A ARYL TRIFLATE COMPOUND, RADIOLOGICALLY ACID PRODUCING AGENT, RADIOLOGICALLY ACID PRODUCING AGENT SYSTEM, AND RADIOSENSITIVE COMPOSITION HITACHI CHEMICAL COMPANY LTD. (JP) 1993-03-30 US claimed
US-12624392-B2 Molecular array generation using photoresist 10X GENOMICS, INC. (US) 2026-05-12 US disclosed
US-20250312504-A1 VOLATILE COMPOSITION DISPENSER FOR COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE THE PROCTER & GAMBLE COMPANY 2025-10-09 US disclosed
US-12344717-B2 General strategy for polymer compatibilization THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-01 US disclosed
EP-4516394-A2 HIGH DEFINITION MOLECULAR ARRAY FEATURE GENERATION USING PHOTORESIST 10x Genomics, Inc. (US) 2025-03-05 EP disclosed
EP-0152377-B1 CURABLE COMPOSITIONS AND THEIR USE CIBA-GEIGY AG (CH) 1987-12-09 EP disclosed
EP-0238672-A1 PROCESS FOR DEOXIDIZING ALCOHOL Yamasa Shoyu Kabushiki Kaisha (JP) 1987-09-30 EP disclosed
EP-0152377-A2 Curable compositions and their use CIBA-GEIGY AG (CH) 1985-08-21 EP disclosed
US-4205005-A Anthraquino-cycloalkane dyes MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-05-27 US disclosed
US-4088482-A XEROGRAPHY, PHOTOSENSITIVITY THE DOW CHEMICAL COMPANY (US) 1978-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624392-B2 Molecular array generation using photoresist POLL, LIG4, LIG3 ALDH1A1 189/4885KDM4E 1169/4885MAPK1 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.